Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Two Regimens of IVIG in Newly Diagnosed Pediatric ITP
NCT05520892Phase 4Recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Oct 2022
- Primary completion
- Aug 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of intravenous immunoglobulin G in immune thrombocytopenia (ITP) (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoint: early response to treatment at 7 days. Started Oct 2022; status: recruiting.
02
Drugs
intravenous immunoglobulin G
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT05520892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05520892.